Stephenson Cancer CenterCancer ResearchCancer Screening Research Network

Cancer Screening Research Network

OK TRUST

Principal Investigators: Mark Doescher, M.D., University of Oklahoma and, Kathleen Moore, M.D., University of Oklahoma

In 2024 OU Health Stephenson Cancer Center joined the National Cancer Institute’s Cancer Screening Research Network (CSRN) with a $3.2 million grant. They are studying new cancer screening methods, especially for high-risk Oklahomans with limited access to screening.

Sign Up to Participate in the Vanguard Study

The Vanguard Study, sponsored by the National Cancer Institute, is testing a new way to screen for multiple cancers. If you’re between the ages of 45-75 and haven’t had cancer recently, you could qualify.

If you have any questions or are interested in participating in the Vanguard Study, you can reach our research team through email at oktrust@ou.edu and leave your contact information or via calling (405) 271-8001 ext. 33524.

EMAIL US TO SIGN UP

Stephenson Cancer Center is one of nine groups nationwide to participate in the network. The project will offer clinical trials to people in tribal, rural, and urban locations across Oklahoma. This effort is known as the Oklahoma Tribal, Rural, Urban Cancer Screening Trial (OK TRUST) Access Hub.

Multi-Cancer Detection Assays

Vanguard Study
The first trial, the Vanguard study, will set the stage for future trials. The screening data will help researchers check how well multi-cancer detection assays (MCDs) find cancer. This trial will also help us identify screening barriers.

MCDs will be used to screen for multiple cancers using a blood draw. Positive results will lead to further tests like magnetic resonance imaging (MRI) or computed tomography (CT) scans. This will help us understand whether MCDs help detect cancer earlier, leading to more effective treatment to reduce cancer-related deaths.

You may be able to participate if you:

Are between 45 to 75 years old.
Have not been diagnosed with cancer in the past 5 years.
Can give 2 blood samples and answer surveys.

If you have any questions or are interested in participating in the Vanguard Study, you can reach our research team through email at oktrust@ou.edu and leave your contact information or via calling (405) 271-8001 ext. 33524.

Stephenson Cancer Center, Oklahoma’s only NCI-designated cancer center, aims to improve cancer screening by adding this screening clinical trial to their existing clinical trials network.